期刊文献+

累及甲状腺的朗格汉斯组织细胞增生症6例报道及文献复习 被引量:3

Langerhans' Cell Histocytosis with Thyroid Involvement:Report of Six Cases and Literature Review
下载PDF
导出
摘要 目的:探讨累及甲状腺的朗格汉斯组织细胞增生症( Langerhans’ cell histocytosis, LCH)的临床特点。方法回顾性分析2004年1月至2014年12月北京协和医院明确诊断有甲状腺受累的6例LCH患者的临床资料并总结其临床表现、诊断、治疗和预后情况。结果6例患者中男性4例,女性2例,起病年龄9~24岁,平均年龄(16.1±5.7)岁;6例患者均有垂体后叶受累,4例有肺脏受累,3例有肝脏受累;4例患者甲状腺自身抗体阴性,2例阳性;4例患者通过甲状腺粗针穿刺活检获得病理证实;5例患者采用化疗方案治疗;随访4例患者中3例病情稳定无进展。结论在有多器官受累的甲状腺肿大患者中,需进一步排除LCH甲状腺受累的可能性,必要时进行甲状腺穿刺,特别是粗针穿刺以明确病理诊断,同时在LCH甲状腺受累患者中要特别注意有无肝脏受累。 Objective To investigate the clinical characteristics of Langerhans’ cell histocytosis ( LCH ) involving the thyroid gland. Methods We reviewed 6 cases of histologically confirmed LCH with thyroid gland involvement in Peking Union Medical College Hospital in the period of January 2004 to December 2014 and ana-lyzed their clinical menifestations, diagnosis, treatment, and prognosis. Results There were 4 males and 2 fe-males in the 6 patients, whose ages of onset were 9-24 years with a mean age of (16. 1 ± 5. 7) years. All the 6 cases had posterior pituitary involvement, 4 cases had lung involvement, and 3 cases had liver involvement. There were 4 cases with negative thyroid autoantibodies and 2 cases with positive thyroid autoantibodies. Four ca-ses were pathologically confirmed by core-needle aspiration biopsy. Five cases were treated with chemotherapy. In the 4 cases followed up, 3 were in progress-free stable status. Conclusions LCH with thyroid involvement should be considered in thyromegaly patients with multiple organs involvement. Thyroid aspiration, especially core-needle aspiration biopsy, is required to confirm pathological diagnosis if necessary. Special attention should be paid to detect liver involvement in patients with thyroid LCH.
出处 《协和医学杂志》 2015年第5期333-337,共5页 Medical Journal of Peking Union Medical College Hospital
基金 国家临床重点专科建设项目(WBYZ2011-873)
关键词 朗格汉斯组织细胞增生症 甲状腺疾病 Langerhans’ cell histocytosis thyroid disease
  • 相关文献

参考文献21

  • 1Willman CL, Busque L, Griffith BB, et al. Langerhans-eell histiocytosis (histiocytosis X) a clonal proliferative dis- ease [J]. N Engl J Med, 1994, 331 : 154-160.
  • 2Yu RC, Chu C, Buluwela L, et al. Clonal proliferation of Langerhans cells in Langerhans cell histiocytosis [Jl. Lan- cet, 1994, 343: 767-768.
  • 3Donadieu J, Rolon MA, Thomas C, et al. Endocrine involve- ment in pediatric-onset Langerhans' cell histiocytosis: a popu- lation-based study [J]. J Pediatr, 2004, 144: 344-350.
  • 4Nezelof C, Basset F, Rousseau MF. Histiocytosis X histoge- netic arguments for a Langerhans cell origin [ J]. Biomedi- cine, 1973, 18: 365-371.
  • 5Merad M, Manz MG, Karsunky H, et al. Langerhans cells renew in the skin throughout life under steady-state conditions [J]. Nat Immunol, 2002, 3: 1135-1141.
  • 6Brown NA, Furtado LV, Betz BL, et al. High prevalence of somatic MAP2K1 mutations in BRAF V60OE-negative Langer- hans cell histiocytosis [ J]. Blood, 2014, 124: 1655-1658.
  • 7Haroche J, Cohen-Aubart F, Emile JF, et al. Dramatic effi- cacy of vemurafenib in both multisystemic and refractory Er- dheim-Chester disease and Langerhans cell histiocytosis har- boring the BRAF V600E mutation [J]. Blood, 2013, 121: 1495-1500.
  • 8Howarth DM, Gilchrist GS, Mullan BP, et al. Langerhans cell histiocytosis : diagnosis, natural history, management, and outcome [J]. Cancer, 1999, 85: 2278-2290.
  • 9Lieberman PH, Jones CR, Steinman RM, et al. Langerhans cell (eosinophilic) granulomatosis. A clinicopathologic study encompassing 50 years [J]. Am J Surg Pathol, 1996, 20: 519-552.
  • 10Thompson LD, Wenig BM, Adair CF, et al. Langerhans cell histiocytosis of the thyroid : a series of seven cases and a re- view of the literature [J~. Mod Pathol, 1996, 9: 145-149.

同被引文献12

引证文献3

二级引证文献8

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部